plicamycin has been researched along with Cell Transformation, Neoplastic in 2 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 2 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Bond, GL; Hamir, A; Iwakuma, T; Jackson, JG; Johnson, DG; Levine, AJ; Lozano, G; Maccio, DR; Pant, V; Post, SM; Quintás-Cardama, A | 1 |
Cho, SD; Jung, JY; Ryu, MH; Safe, S; Shin, JA | 1 |
2 other study(ies) available for plicamycin and Cell Transformation, Neoplastic
Article | Year |
---|---|
A high-frequency regulatory polymorphism in the p53 pathway accelerates tumor development.
Topics: Animals; Cell Line, Tumor; Cell Transformation, Neoplastic; Genes, p53; Genetic Predisposition to Disease; Humans; Mice; Neoplasms; Nuclear Proteins; Plicamycin; Polymorphism, Single Nucleotide; Promoter Regions, Genetic; Proto-Oncogene Proteins c-mdm2; RNA, Messenger; Signal Transduction; Sp1 Transcription Factor; Tumor Suppressor Protein p53 | 2010 |
Mithramycin A inhibits myeloid cell leukemia-1 to induce apoptosis in oral squamous cell carcinomas and tumor xenograft through activation of Bax and oligomerization.
Topics: Animals; Antineoplastic Agents; Apoptosis; bcl-2-Associated X Protein; Carcinoma, Squamous Cell; Cell Line, Tumor; Cell Transformation, Neoplastic; Gene Knockdown Techniques; Humans; Mice; Mice, Nude; Mitochondria; Mouth Mucosa; Mouth Neoplasms; Myeloid Cell Leukemia Sequence 1 Protein; Neoplasm Transplantation; Plicamycin; Polymerization; Protein Transport; Proto-Oncogene Proteins c-bcl-2; RNA Interference; Transplantation, Heterologous | 2013 |